Back to search

Article

SH2D2A as a VEGF pathway-related oncogene driving colorectal cancer through mTOR activation

2026-04-24

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> : Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, largely due to tumor metastasis and the lack of reliable prognostic biomarkers and therapeutic targets. The vascular endothelial growth factor (VEGF) pathway plays a pivotal role in CRC progression, yet its regulatory network remains incompletely understood. <bold>Methods...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
65da19d9-093e-5443-bae2-d81dfd46c0bd
DOI
10.21203/rs.3.rs-9084283/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SH2D2A as a VEGF pathway-related oncogene driving colorectal cancer through mTOR activationDOI 10.21203/rs.3.rs-9084283/v1
ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinomaSemantic proximity
Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver MetastasesSemantic proximity
The PLOD2 promotes tumor progression in colorectal cancer through the PI3K-AKT pathwaySemantic proximity
Comprehensive bioinformatic analysis reveals prognostic significance and functional insights of candidate gene expression in colorectal cancerSemantic proximity
Distinct Molecular and Prognostic Profiles of Left- and Right-Sided Colorectal Cancer Revealed by NGS Analysis: The Role of SMAD4 and SETD2 Mutations.Semantic proximity
Pan-Cancer Analysis Reveals SH3TC2 as an Oncogene for Colorectal Cancer and Promotes Tumorigenesis via the MAPK PathwaySemantic proximity
Uncovering Potential Therapeutic Targets in Colorectal Cancer by Deciphering Mutational Status and Expression of Druggable OncogenesSemantic proximity
RGL2 Drives the Metastatic Progression of Colorectal Cancer via Preventing the Protein Degradation of β-catenin and KRASSemantic proximity
LncRNA IGFL2-AS1 Promotes the Proliferation, Migration, and Invasion of Colon Cancer Cells and is Associated with Patient PrognosisSemantic proximity
Evaluation of lncRNA FOXD2-AS1 expression as a diagnostic biomarker in CRCSemantic proximity
Identification of SHC2 as a prognostic biomarker: from pan-cancer analysis to colon adenocarcinoma validationSemantic proximity
DKK2 blockage-mediated immunotherapy enhances anti-angiogenic therapy of Kras mutated colorectal cancer.Semantic proximity
Select a neighboring publication to make it the new centre.